Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies

Overview of attention for article published in Frontiers in immunology, October 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 42,779 followers.

PC | Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies https://t.co/ZznVaBnZKo

16 Nov 2023

Reply Repost Favourite

Case Report: Telitacicept in treating a patient with NF155+ #autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies https://t.co/WnaSluNIB5

16 Nov 2023

Reply Repost Favourite

New Research: Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies: This report presents a case of a neurofascin-155 (NF155)+ autoimmune… https://t.co

30 Oct 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.